These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21469753)

  • 41. The Cartographers toolbox: building bigger and better human protein interaction networks.
    Sanderson CM
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):1-11. PubMed ID: 19282470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subtype-specific roles of phospholipase C-β via differential interactions with PDZ domain proteins.
    Kim JK; Lim S; Kim J; Kim S; Kim JH; Ryu SH; Suh PG
    Adv Enzyme Regul; 2011; 51(1):138-51. PubMed ID: 21035486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PYRIN domains and their interactions in the apoptosis and inflammation signaling pathway.
    Park HH
    Apoptosis; 2012 Dec; 17(12):1247-57. PubMed ID: 23100161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Target network analysis of adiponectin, a multifaceted adipokine.
    Chen X
    J Cell Biochem; 2013 May; 114(5):1145-52. PubMed ID: 23192392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Applications of in Silico Methods for Design and Development of Drugs Targeting Protein-Protein Interactions.
    Cicaloni V; Trezza A; Pettini F; Spiga O
    Curr Top Med Chem; 2019; 19(7):534-554. PubMed ID: 30836920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic investigation of protein-small molecule interactions.
    Li X; Wang X; Snyder M
    IUBMB Life; 2013 Jan; 65(1):2-8. PubMed ID: 23225626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The present and the future of motif-mediated protein-protein interactions.
    Seo MH; Kim PM
    Curr Opin Struct Biol; 2018 Jun; 50():162-170. PubMed ID: 29730529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein Complex Production from the Drug Discovery Standpoint.
    Moarefi I
    Adv Exp Med Biol; 2016; 896():3-13. PubMed ID: 27165315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Describing biological protein interactions in terms of protein states and state transitions: the LiveDIP database.
    Duan XJ; Xenarios I; Eisenberg D
    Mol Cell Proteomics; 2002 Feb; 1(2):104-16. PubMed ID: 12096128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The phytotoxin fusicoccin, a selective stabilizer of 14-3-3 interactions?
    Camoni L; Visconti S; Aducci P
    IUBMB Life; 2013 Jun; 65(6):513-7. PubMed ID: 23568668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein-protein interaction networks studies and importance of 3D structure knowledge.
    Lu HC; Fornili A; Fraternali F
    Expert Rev Proteomics; 2013 Dec; 10(6):511-20. PubMed ID: 24206225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and Development of Drugs Targeting Protein-Protein Interactions - Part-II.
    Gupta SP
    Curr Top Med Chem; 2019; 19(7):500. PubMed ID: 31210104
    [No Abstract]   [Full Text] [Related]  

  • 53. Recent Advances on the Network Models in Target-based Drug Discovery.
    Yan W; Zhang D; Shen C; Liang Z; Hu G
    Curr Top Med Chem; 2018; 18(13):1031-1043. PubMed ID: 30027851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quinary protein structure and the consequences of crowding in living cells: leaving the test-tube behind.
    Wirth AJ; Gruebele M
    Bioessays; 2013 Nov; 35(11):984-93. PubMed ID: 23943406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical candidates modulating protein-protein interactions: The fragment-based experience.
    Valenti D; Hristeva S; Tzalis D; Ottmann C
    Eur J Med Chem; 2019 Apr; 167():76-95. PubMed ID: 30769242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of long-range intermolecular interactions in discovery of new drugs.
    Veljkovic N; Glisic S; Perovic V; Veljkovic V
    Expert Opin Drug Discov; 2011 Dec; 6(12):1263-70. PubMed ID: 22647065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein Interaction Domains and Post-Translational Modifications: Structural Features and Drug Discovery Applications.
    Vincenzi M; Mercurio FA; Leone M
    Curr Med Chem; 2020; 27(37):6306-6355. PubMed ID: 31250750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolution of biophysical tools for quantitative protein interactions and drug discovery.
    Harish M; Venkatraman P
    Emerg Top Life Sci; 2021 May; 5(1):1-12. PubMed ID: 33739398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detecting and interfering protein interactions: towards the control of biochemical pathways.
    Morell M; Avilés FX; Ventura S
    Curr Med Chem; 2009; 16(3):362-79. PubMed ID: 19149583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The emergence of protein complexes: quaternary structure, dynamics and allostery. Colworth Medal Lecture.
    Perica T; Marsh JA; Sousa FL; Natan E; Colwell LJ; Ahnert SE; Teichmann SA
    Biochem Soc Trans; 2012 Jun; 40(3):475-91. PubMed ID: 22616857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.